Unnatural Products
Unnatural Products is a California-based biotech company pioneering a novel drug discovery platform that engineers synthetic macrocycles to target complex, traditionally undruggable proteins. Their AI-enhanced platform designs, synthesizes, and screens cyclic peptide macrocycles that combine the cell permeability and oral bioavailability of small molecules with the specificity of biologics. This innovative approach addresses about 70% of drug targets that are inaccessible to conventional small molecules and biologics, positioning the company at the forefront of next-generation therapeutics. Their technology has attracted significant partnerships, including a $220M deal with Merck & Co., underscoring their market traction and potential to transform medicine by enabling treatments for hard-to-drug targets.
Unnatural Products
Unnatural Products is a California-based biotech company pioneering a novel drug discovery platform that engineers synthetic macrocycles to target complex, traditionally undruggable proteins. Their AI-enhanced platform designs, synthesizes, and screens cyclic peptide macrocycles that combine the cell permeability and oral bioavailability of small molecules with the specificity of biologics. This innovative approach addresses about 70% of drug targets that are inaccessible to conventional small molecules and biologics, positioning the company at the forefront of next-generation therapeutics. Their technology has attracted significant partnerships, including a $220M deal with Merck & Co., underscoring their market traction and potential to transform medicine by enabling treatments for hard-to-drug targets.